LONE TREE, CO — October 6, 2025 — Cochlear North America is proud to announce its recognition as a gold winner in two categories at the prestigious 2025 Hearing Health […]
On July 14, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that announces and solicits public comments on proposed policy changes for Medicare payments under […]
[LONE TREE, CO, July 8, 2025]: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of the Cochlear™ […]
We’re past the half-year mark—it’s a great time for eligible patients to consider using their 2025 insurance benefits to replace their CochlearTM sound processor. Cochlear will be reaching out […]
Written by Guest Author, Dr. Abby Meyer, MD, MPH, FAAP Congenital cytomegalovirus (cCMV) infection is the most common congenital infection with an estimated prevalence of approximately 1 in 200 births. […]
On March 15, 2025, Congress passed, and the President signed into law, H.R.1968 – Full-Year Continuing Appropriations and Extensions Act, 2025. An extension of the telehealth waivers allowing services by […]
On December 20, 2024, President Biden signed into law the American Relief Act (H.R. 10545). A three-month extension of the current Medicare telehealth services is included within this law. Additional […]
We are thrilled to launch our new online payment platform designed exclusively for your patients who process orders using their insurance through Cochlear’s Reimbursement and Insurance Services. This innovative platform […]
We’re past the half-year mark—it’s a great time for eligible patients to consider using their 2024 insurance benefits to replace their CochlearTM sound processor. Cochlear will be reaching out […]
Patients can choose to have their Cochlear Nucleus® or Kanso® Sound Processor upgrade shipped Ready-to-Wear so they can wear it right out of the box.
End of content
No more pages to load
